{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:48:30Z","timestamp":1788194910900,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008385","name":"Fondazione per La Ricerca sulla Fibrosi Cistica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"ERC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jconrel.2024.08.029","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T17:16:54Z","timestamp":1724692614000},"page":"454-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Antibiotic-loaded nanoparticles for the treatment of intracellular methicillin-resistant Staphylococcus Aureus infections: In vitro and in vivo efficacy of a novel antibiotic"],"prefix":"10.1016","volume":"374","author":[{"given":"Gabriella","family":"Costabile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domizia","family":"Baldassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Gro\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ungaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Firestine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia M.","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jconrel.2024.08.029_bb0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","article-title":"Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research","volume":"17","author":"Turner","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.08.029_bb0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41392-023-01722-y","article-title":"Lung microbiome: new insights into the pathogenesis of respiratory diseases","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2024.08.029_bb0015","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CMR.15.2.194-222.2002","article-title":"Lung infections associated with cystic fibrosis","volume":"15","author":"Lyczak","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2024.08.029_bb0020","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ijc.31098","article-title":"Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects","volume":"142","author":"Liu","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.jconrel.2024.08.029_bb0025","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","article-title":"Commensal microbiota promote lung cancer development via \u03b3\u03b4 T cells","volume":"176","author":"Jin","year":"2019","journal-title":"Cell."},{"issue":"6","key":"10.1016\/j.jconrel.2024.08.029_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061447","article-title":"Comparative analysis of age- and gender-associated microbiome in lung adenocarcinoma and lung squamous cell carcinoma","volume":"12","author":"Wong","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2024.08.029_bb0035","article-title":"Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses","author":"Wang","year":"2023","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.jconrel.2024.08.029_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tim.2008.11.005","article-title":"Staphylococcus aureus: new evidence for intracellular persistence","volume":"17","author":"Garzoni","year":"2009","journal-title":"Trends Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.08.029_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001409","article-title":"A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages","volume":"3","author":"Kubica","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jconrel.2024.08.029_bb0050","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1038\/s41598-018-22245-5","article-title":"Increased intracellular activity of MP1102 and NZ2114 against Staphylococcus aureus in vitro and in vivo","volume":"8","author":"Wang","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.jconrel.2024.08.029_bb0055","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41385-022-00529-4","article-title":"Staphylococcus aureus specific lung resident memory CD4(+) Th1 cells attenuate the severity of influenza virus induced secondary bacterial pneumonia","volume":"15","author":"Braverman","year":"2022","journal-title":"Mucosal Immunol."},{"issue":"16","key":"10.1016\/j.jconrel.2024.08.029_bb0060","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1021\/jm900519b","article-title":"Design, synthesis, and structure-activity relationships of benzophenone-based tetraamides as novel antibacterial agents","volume":"52","author":"Vooturi","year":"2009","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2024.08.029_bb0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/cc900138h","article-title":"Solution-phase parallel synthesis of novel membrane-targeted antibiotics","volume":"12","author":"Vooturi","year":"2010","journal-title":"J. Comb. Chem."},{"issue":"18","key":"10.1016\/j.jconrel.2024.08.029_bb0070","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1039\/c1ob05643c","article-title":"Examination of a synthetic benzophenone membrane-targeted antibiotic","volume":"9","author":"Vooturi","year":"2011","journal-title":"Org. Biomol. Chem."},{"issue":"6","key":"10.1016\/j.jconrel.2024.08.029_bb0075","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ijantimicag.2014.02.009","article-title":"Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections","volume":"43","author":"Abed","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jconrel.2024.08.029_bb0080","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jconrel.2020.03.037","article-title":"Intracellular bacteria destruction via traceable enzymes-responsive release and deferoxamine-mediated ingestion of antibiotics","volume":"322","author":"Chen","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.08.029_bb0085","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jconrel.2020.08.048","article-title":"Novel antibiotic-loaded particles conferring eradication of deep tissue bacterial reservoirs for the treatment of chronic urinary tract infection","volume":"328","author":"Lau","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.08.029_bb0090","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jconrel.2018.04.040","article-title":"Clearance of intracellular Klebsiella pneumoniae infection using gentamicin-loaded nanoparticles","volume":"279","author":"Jiang","year":"2018","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2024.08.029_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16030347","article-title":"State-of-the-art review on inhalable lipid and polymer nanocarriers: design and development perspectives","volume":"16","author":"Costabile","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.08.029_bb0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2014.10.022","article-title":"Inhaled formulations and pulmonary drug delivery systems for respiratory infections","volume":"85","author":"Zhou","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2024.08.029_bb0105","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.drudis.2014.09.020","article-title":"Recent advances in controlled pulmonary drug delivery","volume":"20","author":"Liang","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"6","key":"10.1016\/j.jconrel.2024.08.029_bb0110","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/wnan.1401","article-title":"Polymeric nanoparticles in development for treatment of pulmonary infectious diseases","volume":"8","author":"Lim","year":"2016","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2024.08.029_bb0115","article-title":"PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection","volume":"23","author":"Costabile","year":"2020","journal-title":"Nanomedicine."},{"issue":"1","key":"10.1016\/j.jconrel.2024.08.029_bb0120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/21505594.2019.1621649","article-title":"Galleria mellonella as a consolidated in vivo model hosts: new developments in antibacterial strategies and novel drug testing","volume":"10","author":"Cutuli","year":"2019","journal-title":"Virulence."},{"issue":"8","key":"10.1016\/j.jconrel.2024.08.029_bb0125","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1208\/s12249-018-1187-9","article-title":"Physicochemical and in vitro evaluation of drug delivery of an antibacterial synthetic benzophenone in biodegradable PLGA nanoparticles","volume":"19","author":"Costabile","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2024.08.029_bb0130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejpb.2017.04.032","article-title":"Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections","volume":"117","author":"G\u00fcnday T\u00fcreli","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.jconrel.2024.08.029_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040232","article-title":"Evaluation of \u03b2-Sitosterol loaded PLGA and PEG-PLA nanoparticles for effective treatment of breast cancer: preparation, physicochemical characterization, and antitumor activity","volume":"10","author":"Andima","year":"2018","journal-title":"Pharmaceutics."},{"issue":"5","key":"10.1016\/j.jconrel.2024.08.029_bb0140","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.nantod.2011.08.012","article-title":"Advances in resistive pulse sensors: devices bridging the void between molecular and microscopic detection","volume":"6","author":"Kozak","year":"2011","journal-title":"Nano Today"},{"issue":"3","key":"10.1016\/j.jconrel.2024.08.029_bb0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0939-6411(98)00004-6","article-title":"Freeze-drying of bioproducts: putting principles into practice","volume":"45","author":"Franks","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2024.08.029_bb0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0378-5173(01)00944-9","article-title":"Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles","volume":"233","author":"Konan","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2024.08.029_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.03.017","article-title":"Formulation strategy and use of excipients in pulmonary drug delivery","volume":"392","author":"Pilcer","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.jconrel.2024.08.029_bb0160","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1021\/acs.molpharmaceut.5b00098","article-title":"Toward repositioning niclosamide for antivirulence therapy of Pseudomonas aeruginosa lung infections: development of inhalable formulations through nanosuspension technology","volume":"12","author":"Costabile","year":"2015","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.jconrel.2024.08.029_bb0165","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/jps.23077","article-title":"Cyclodextrins as functional excipients: methods to enhance complexation efficiency","volume":"101","author":"Loftsson","year":"2012","journal-title":"J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.jconrel.2024.08.029_bb0170","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.xphs.2018.03.021","article-title":"Role of cyclodextrins in nanoparticle-based drug delivery systems","volume":"107","author":"Shelley","year":"2018","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2024.08.029_bb0175","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1080\/21691401.2019.1683567","article-title":"Characterisation of 2-HP-\u03b2-cyclodextrin-PLGA nanoparticle complexes for potential use as ocular drug delivery vehicles","volume":"47","author":"Li","year":"2019","journal-title":"Artif Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.08.029_bb0180","series-title":"Strategies to Modify the Drug Release from Pharmaceutical Systems","first-page":"63","article-title":"5 - mathematical models of drug release","year":"2015"},{"issue":"2","key":"10.1016\/j.jconrel.2024.08.029_bb0185","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"89","author":"Denizot","year":"1986","journal-title":"J. Immunol. Methods"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2024.08.029_bb0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2024.08.029_bb0195","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40005-019-00439-x","article-title":"Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)\/poly(lactic-co-glycolic acid) micro and nanoparticles","volume":"49","author":"Elmowafy","year":"2019","journal-title":"J. Pharm. Investig."},{"issue":"6","key":"10.1016\/j.jconrel.2024.08.029_bb0200","article-title":"Analysis of cell viability by the lactate dehydrogenase assay","volume":"2018","author":"Kumar","year":"2018","journal-title":"Cold Spring Harb Protoc"},{"issue":"8","key":"10.1016\/j.jconrel.2024.08.029_bb0205","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050348","article-title":"Macrophage-driven nutrient delivery to phagosomal Staphylococcus aureus supports bacterial growth","volume":"21","author":"Flannagan","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jconrel.2024.08.029_bb0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2017.08.007","article-title":"Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages","volume":"267","author":"Pei","year":"2017","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2024.08.029_bb0215","doi-asserted-by":"crossref","first-page":"105848","DOI":"10.1016\/j.ijantimicag.2019.11.005","article-title":"Cellular pharmacokinetics and intracellular activity of the bacterial fatty acid synthesis inhibitor, afabicin desphosphono against different resistance phenotypes of Staphylococcus aureus in models of cultured phagocytic cells","volume":"55","author":"Peyrusson","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"48","key":"10.1016\/j.jconrel.2024.08.029_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202004942","article-title":"Coating of a novel antimicrobial nanoparticle with a macrophage membrane for the selective entry into infected macrophages and killing of intracellular staphylococci","volume":"30","author":"Li","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"7","key":"10.1016\/j.jconrel.2024.08.029_bb0225","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/mabi.201000496","article-title":"Biodegradable poly(ethylene carbonate) nanoparticles as a promising drug delivery system with \u201cstealth\u201d potential","volume":"11","author":"Bege","year":"2011","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2024.08.029_bb0230","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2019.09.002","article-title":"Carbohydrate-based nanocarriers and their application to target macrophages and deliver antimicrobial agents","volume":"151\u2013152","author":"Mosaiab","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2024.08.029_bb0235","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2741\/3627","article-title":"Drug delivery systems for potential treatment of intracellular bacterial infections","volume":"15","author":"Imbuluzqueta","year":"2010","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jconrel.2024.08.029_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113948","article-title":"Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections","volume":"177","author":"Subramaniam","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2024.08.029_bb0245","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/21505594.2015.1135289","article-title":"Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing","volume":"7","author":"Tsai","year":"2016","journal-title":"Virulence."},{"key":"10.1016\/j.jconrel.2024.08.029_bb0250","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jconrel.2023.12.010","article-title":"Amphotericin B-loaded natural latex dressing for treating Candida albicans wound infections using galleria mellonella model","volume":"365","author":"Herculano","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.08.029_bb0255","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jconrel.2014.11.022","article-title":"Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase)","volume":"198","author":"Deacon","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.08.029_bb0260","doi-asserted-by":"crossref","first-page":"114378","DOI":"10.1016\/j.addr.2022.114378","article-title":"Novel antimicrobial agents for combating antibiotic-resistant bacteria","volume":"187","author":"Chang","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.08.029_bb0265","doi-asserted-by":"crossref","DOI":"10.5772\/48175","article-title":"Staphylococcus aureus: characterisation and quantitative growth description in milk and artisanal raw milk cheese production","volume":"June 2014","author":"Medveov","year":"2012","journal-title":"Struct Funct. Food Eng."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924005777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924005777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:45:00Z","timestamp":1741239900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924005777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":53,"alternative-id":["S0168365924005777"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.08.029","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic-loaded nanoparticles for the treatment of intracellular methicillin-resistant Staphylococcus Aureus infections: In vitro and in vivo efficacy of a novel antibiotic","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}